Holen Sie sich die Stockscreener-App
1.98
1.00%
-0.02
Handel nachbörslich:
1.96
-0.02
-1.01%
Schlusskurs vom Vortag:
$2.00
Offen:
$2.02
24-Stunden-Volumen:
1.30M
Relative Volume:
0.85
Marktkapitalisierung:
$184.38M
Einnahmen:
$34.48M
Nettoeinkommen (Verlust:
$-102.07M
KGV:
-1.3562
EPS:
-1.46
Netto-Cashflow:
$-104.90M
1W Leistung:
+10.00%
1M Leistung:
-13.16%
6M Leistung:
+70.69%
1J Leistung:
-8.33%
1-Tages-Spanne:
$1.945
$2.1594
1-Wochen-Bereich:
$1.74
$2.1594
52-Wochen-Spanne:
$0.66
$2.9995
Caribou Biosciences Inc Stock (CRBU) Company Profile
Firmenname
Caribou Biosciences Inc
Sektor
Branche
Telefon
510-982-6030
Adresse
2929 7TH STREET, SUITE 105, BERKELEY
Vergleichen Sie CRBU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.98 | 186.25M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-11-08 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-10-31 | Eingeleitet | Evercore ISI | Outperform |
| 2023-07-11 | Eingeleitet | Truist | Buy |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-17 | Eingeleitet | BofA Securities | Buy |
| 2021-08-17 | Eingeleitet | Citigroup | Neutral |
| 2021-08-17 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten
Historical volatility pattern of Caribou Biosciences Inc. visualizedGDP Growth & Technical Entry and Exit Alerts - Newser
Why Caribou Biosciences Inc. is moving todayJuly 2025 Recap & Free Technical Pattern Based Buy Signals - Newser
Published on: 2025-08-27 13:44:57 - Newser
August 2025's Top Penny Stocks With Growth Potential - Yahoo Finance
What the charts say about Caribou Biosciences Inc. todayWeekly Gains Report & Free Community Consensus Stock Picks - Newser
Published on: 2025-08-27 10:50:07 - Newser
Caribou Biosciences Inc. stock prediction for this weekJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - Newser
Will Caribou Biosciences Inc. benefit from green energy policies2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - sundaytimes.kr
Is a relief rally coming for Caribou Biosciences Inc. holdersTrade Entry Summary & Low Volatility Stock Suggestions - Newser
Can Caribou Biosciences Inc. Overcome Bearish Sentiment getLinesFromResByArray error: size == 0 - newsyoung.net
Long term hold vs stop loss in Caribou Biosciences Inc.Stop Loss & Accurate Trade Setup Notifications - Newser
Evercore ISI Initiates Coverage of Caribou Biosciences with Hold Rating and $1.00 Price Target - AInvest
Published on: 2025-08-26 13:57:11 - Newser
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference - The Manila Times
Applying big data sentiment scoring on Caribou Biosciences Inc.Weekly Stock Analysis & Free Fast Gain Swing Trade Alerts - Newser
Is now a turning point for Caribou Biosciences Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Sentiment Watch: What are the future prospects of Caribou Biosciences Inc.2025 Pullback Review & Verified Chart Pattern Trade Signals - sundaytimes.kr
Aug Rallies: How does Caribou Biosciences Inc. score in quality rankingsJuly 2025 Decliners & Free High Accuracy Swing Entry Alerts - theviewers.co.kr
Is Caribou Biosciences Inc. forming a bottoming baseChart Signals & Stepwise Swing Trade Plans - Newser
Chart Analysts Warn of Resistance Near Caribou Biosciences Inc. PriceJuly 2025 Patterns & Free Low Drawdown Momentum Trade Ideas - beatles.ru
Top chart patterns to watch in Caribou Biosciences Inc.Global Markets & Short-Term High Return Ideas - Newser
Caribou Biosciences reports Q2 EPS (35c), one estimate (42c) - MSN
Momentum Screeners Rank Caribou Biosciences, Inc. in Top 5 TodayJuly 2025 Update & Low Risk Growth Stock Ideas - 더경남뉴스
Leading vs lagging indicators on Caribou Biosciences Inc. performanceQuarterly Profit Summary & Expert Verified Movement Alerts - Newser
Caribou Biosciences Inc. Pullback Analyzed — Is It Time to Exit2025 Sector Review & Short-Term High Return Ideas - kangso.co.kr
Caribou Biosciences Inc.’s Price Action Aligns with Quant SignalsWeekly Trade Review & AI Powered Buy/Sell Recommendations - beatles.ru
How does Caribou Biosciences Inc. score in quality rankingsCPI Data & Expert Verified Movement Alerts - 선데이타임즈
Using economic indicators to assess Caribou Biosciences Inc. potentialJuly 2025 Institutional & Stepwise Swing Trade Plans - Newser
Using data tools to time your Caribou Biosciences Inc. exit2025 Trade Ideas & Scalable Portfolio Growth Ideas - Newser
Is Caribou Biosciences Inc. Forming a Bottom PatternGlobal Markets & Reliable Entry Point Alerts - metal.it
What’s the recovery path for long term holders of Caribou Biosciences Inc.Analyst Upgrade & Scalable Portfolio Growth Methods - Newser
Truist Financial analyst assigns Buy rating to Caribou Biosciences with $3.50 price target. - AInvest
RBC Capital Maintains Buy Rating for Caribou Biosciences with $10 Price Target - AInvest
Caribou Biosciences: Strong Clinical Progress and Financial Health Justify Buy Rating with $3.00 Target - AInvest
Caribou Biosciences: Promising Clinical Progress and Strong Financial Position Justify Buy Rating - TipRanks
Caribou Biosciences Reports Wider Q2 Loss Amid Increased R&D Spending - AInvest
Caribou Biosciences Reports Increased Losses Amid R&D Efforts - TipRanks
Navigating the Storm: Caribou Biosciences' Strategic Rebalancing and the Road to Gene-Editing Dominance - AInvest
Caribou Biosciences earnings beat by $0.04, revenue topped estimates - Investing.com Canada
Caribou Biosciences Q2 2025: $184mln cash, H2 2027 funding, CB-010 & CB-011 data in H2 2025. - AInvest
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Is Caribou Biosciences Inc. Forming a Consolidation BaseTrade Setups With Clear Risk Limits Highlighted - beatles.ru
Caribou Biosciences CRBU Q2 2025 Earnings Preview Downside Risk Amid Clinical Trial Delays - AInvest
Sentiment Tools Show Shift in Trader Mood on Caribou Biosciences Inc.Exit Ready Momentum Stock Watchlist Expanded - beatles.ru
Published on: 2025-08-05 08:29:24 - metal.it
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU - ACCESS Newswire
Can volume confirm reversal in Caribou Biosciences Inc.Expert-Backed High Yield Stock Watchlist - Newser
Caribou Biosciences Inc. Price Targets Raised After ReboundWeekly Hot Picks With Buy Confidence Released - metal.it
Finanzdaten der Caribou Biosciences Inc-Aktie (CRBU)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):